WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H463044
CAS#: 110882-85-4
Description: Parvodicin C2 is a glycopeptide antibiotic originally isolated from A. parvosata and a component of parvodicin complex. It is also a component of the A40926 antibiotic complex, which has been used as a precursor in the synthesis of the antibiotic dalbavancin. Parvodicin C2 is active against methicillin-sensitive strains of S. aureus, S. epidermidis, and S. saprophyticus, as well as methicillin-resistant strains of S. aureus, S. hemolyticus, and E. faecalis.
Hodoodo Cat#: H463044
Name: Parvodicin C2
CAS#: 110882-85-4
Chemical Formula: C83H88Cl2N8O29
Exact Mass: 1,730.50
Molecular Weight: 1,732.544
Elemental Analysis: C, 57.54; H, 5.12; Cl, 4.09; N, 6.47; O, 26.78
Synonym: Parvodicin C2; Antibiotic A40926 B1;
IUPAC/Chemical Name: 5,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(1-oxododecyl)amino]-β-D-glucopyranuronosyl]-42-O-α-D-mannopyranosyl-N15-methyl-ristomycin A aglycone
InChi Key: IMGYVEMZPBHISV-PSDJNXLUSA-N
InChi Code: InChI=1S/C83H88Cl2N8O29/c1-3-4-5-6-7-8-9-10-11-12-56(99)88-65-68(102)70(104)73(81(114)115)122-82(65)121-72-53-27-38-28-54(72)118-50-22-17-37(25-45(50)84)66(100)64-79(111)92-63(80(112)113)43-29-39(95)30-52(119-83-71(105)69(103)67(101)55(33-94)120-83)57(43)42-24-35(15-20-47(42)96)60(76(108)93-64)89-77(109)61(38)90-78(110)62-44-31-41(32-49(98)58(44)85)117-51-26-36(16-21-48(51)97)59(86-2)75(107)87-46(74(106)91-62)23-34-13-18-40(116-53)19-14-34/h13-22,24-32,46,55,59-71,73,82-83,86,94-98,100-105H,3-12,23,33H2,1-2H3,(H,87,107)(H,88,99)(H,89,109)(H,90,110)(H,91,106)(H,92,111)(H,93,108)(H,112,113)(H,114,115)/t46-,55-,59-,60-,61-,62+,63+,64+,65-,66-,67-,68-,69+,70+,71+,73+,82-,83+/m1/s1
SMILES Code: OC([C@@H](NC([C@]([C@@H](C1=CC=C(O2)C(Cl)=C1)O)(NC3=O)[H])=O)C4=CC(O)=CC(O[C@H]([C@H]([C@H]5O)O)O[C@@H]([C@H]5O)CO)=C4C6=CC([C@@]3([H])NC([C@@]7(NC([C@](C8=C(C(O)=CC9=C8)Cl)(NC([C@@](NC([C@@H](C%10=CC(O9)=C(C=C%10)O)NC)=O)([H])CC%11=CC=C(OC%12=CC7=CC2=C%12O[C@H](O[C@@H]%13C(O)=O)[C@@H]([C@H]([C@@H]%13O)O)NC(CCCCCCCCCCC)=O)C=C%11)=O)[H])=O)[H])=O)=CC=C6O)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 1,732.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |